News
Merck KGaA Sees Single-Digit Serono Sales Growth as Erbitux Revenue Rises Bloomberg
View ArticleMerck KGaA tries again on Erbitux for lung cancer
Merck KGaA tries again on Erbitux for lung cancer Fierce Pharma
View ArticleQiagen Completes Second U.S. Submission For Companion Diagnostic To Guide...
Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer Biomed Reports
View ArticleQiagen: FDA Submissions May Make This Bottom Bouncer More Appealing
Qiagen: FDA Submissions May Make This Bottom Bouncer More Appealing Seeking Alpha
View ArticleHarvard Scientists Discover How Cancer Outwits Erbitux Drug
Harvard Scientists Discover How Cancer Outwits Erbitux Drug Bloomberg
View ArticleBristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use Bloomberg
View ArticleOn The Heels Of Chemo-Approved Cancer Drugs
On The Heels Of Chemo-Approved Cancer Drugs Seeking Alpha
View ArticleMerck KGaA Says Erbitux Fails In Stomach Cancer Trial
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial Bloomberg
View ArticleBristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use Bloomberg
View ArticleFDA OKs screening test for colon cancer drug
FDA OKs screening test for colon cancer drug Yahoo/AP
View ArticleBig Pharmas: New Drugs Will Make You Money
Big Pharmas: New Drugs Will Make You Money Seeking Alpha
View ArticleMerck KGaA pulls second lung cancer drug filing
Merck KGaA pulls second lung cancer drug filing Reuters
View ArticleWill What Happened to Lilly in 2012 Stay in 2012?
Will What Happened to Lilly in 2012 Stay in 2012? Motley Fool
View ArticleEli Lilly Sues Genentech Seeking to Invalidate Cabilly Patents
Eli Lilly Sues Genentech Seeking to Invalidate Cabilly Patents Bloomberg
View ArticleCan Bristol-Myers Squibb Compete In Immuno-Oncology?
Can Bristol-Myers Squibb Compete In Immuno-Oncology? Seeking Alpha
View ArticleErbitux Tops Roche’s Avastin for Colon Cancer Survival
Erbitux Tops Roche’s Avastin for Colon Cancer Survival Bloomberg
View ArticleMerck KGaA's Drug Tops Roche's Avastin for Colon Cancer
Merck KGaA's Drug Tops Roche's Avastin for Colon Cancer Bloomberg
View ArticleGermany's Merck sees long-term growth in cancer drug Erbitux
Germany's Merck sees long-term growth in cancer drug Erbitux Yahoo/Reuters
View ArticleASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life? Yahoo/Benzinga
View Article
